These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 9051188)
21. DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Coleman K; Baak JP; van Diest PJ; Curran B; Mullaney J; Fenton M; Leader M Hum Pathol; 1995 Jan; 26(1):99-105. PubMed ID: 7821923 [TBL] [Abstract][Full Text] [Related]
22. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252 [TBL] [Abstract][Full Text] [Related]
23. Bone metastases: prognostic applications of cytometric DNA analysis. Herget GW; Smolka W; Adler CP; Uhl M; Kreuz PC; Knoller SM Anal Quant Cytol Histol; 2004 Aug; 26(4):217-22. PubMed ID: 15457674 [TBL] [Abstract][Full Text] [Related]
24. Improved detection of aneuploidy in malignant melanoma using multiparameter flow cytometry for S100 protein and DNA content. Kamino H; Ratech H J Invest Dermatol; 1989 Sep; 93(3):392-6. PubMed ID: 2768839 [TBL] [Abstract][Full Text] [Related]
25. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry. Williams RA; Rode J; Baak JP; Charlton IG Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514 [TBL] [Abstract][Full Text] [Related]
26. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis. Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325 [TBL] [Abstract][Full Text] [Related]
27. DNA-index and stereological estimation of nuclear volume in primary and metastatic malignant melanomas: a comparative study with analysis of heterogeneity. Sørensen FB; Kristensen IB; Grymer F; Jakobsen A APMIS; 1990 Jan; 98(1):61-70. PubMed ID: 2302343 [TBL] [Abstract][Full Text] [Related]
28. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882 [TBL] [Abstract][Full Text] [Related]
29. [Characteristics of the DNA content in the cells of human pigmented nevi and of beginning and developed malignant melanomas of the skin]. Naleskina LA; Avtandilov GG Tsitol Genet; 1987; 21(6):446-9. PubMed ID: 3445364 [TBL] [Abstract][Full Text] [Related]
31. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions. Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505 [TBL] [Abstract][Full Text] [Related]
32. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors. Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions. Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA image cytometry in Libyan breast cancer. Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y Oncology; 2012; 83(3):165-76. PubMed ID: 22906963 [TBL] [Abstract][Full Text] [Related]
35. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past. Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma. Tan GJ; Baak JP Anal Quant Cytol; 1984 Sep; 6(3):147-54. PubMed ID: 6508033 [TBL] [Abstract][Full Text] [Related]
37. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma. Binder M; Dolezal I; Wolff K; Pehamberger H J Invest Dermatol; 1992 Aug; 99(2):180-3. PubMed ID: 1629630 [TBL] [Abstract][Full Text] [Related]
38. DNA ploidy and cell cycle analysis in ear malignant melanoma by flow and image cytometry. Cohen C; Walker BF; Solomon AR; DeRose PB Anal Quant Cytol Histol; 1992 Apr; 14(2):81-8. PubMed ID: 1590901 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the malignancy in gallbladder cancer assessed by nuclear DNA contents and mitotic indices--with special reference to the prognosis of the patients with cancer involvement to the subserosal layer]. Sato Y; Tanaka J; Yoshioka H; Koyama K Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):46-51. PubMed ID: 2014025 [TBL] [Abstract][Full Text] [Related]